- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Vivos Therapeutics, Inc: Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy | 2 | GlobeNewswire (USA) | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 28.02. | New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd., CitroTech, Vivos Therapeutics, Inc., and Virtuix Holdings on Bloomberg Television Tonight at 6:30 PM EST | 595 | ACCESS Newswire | The Show Will Also Air Across Latin America and MENA 1230 pm local time. NEW YORK CITY, NEW YORK / ACCESS Newswire / February 28, 2026 / New to The Street will broadcast nationally tonight at 6:30 PM... ► Artikel lesen | |
| 14.02. | New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics, Aeries Technology, Virtuix Holdings, and Stardust Power | 692 | ACCESS Newswire | The show broadcasts as sponsored programming with national TV commercials from Synergy CHC (NASDAQ:SNYR), NeOnc Technologies (NASDAQ:NTHI), PetVivo (OTCQX:PETV), and YY Group Holdings (NASDAQ:YYGH).... ► Artikel lesen | |
| 06.02. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.02. | Vivos Therapeutics, Inc: Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies | 5 | GlobeNewswire (USA) | ||
| 05.02. | VIVOS Therapeutics, Inc. Signs 12-Part Media Series with New to The Street | 344 | ACCESS Newswire | Twelve months of national and global coverage to include long-form interviews, earned media, television commercials, iconic outdoor billboards, and accredited investor events NEW YORK CITY, NEW YORK... ► Artikel lesen | |
| 20.01. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds | 1 | GlobeNewswire (USA) | ||
| 16.01. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.01. | Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds | 2 | Seeking Alpha | ||
| 16.01. | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds | 1 | GlobeNewswire (USA) | ||
| 16.12.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan | 2 | GlobeNewswire (USA) | ||
| 15.12.25 | Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST | 1 | GlobeNewswire (USA) | ||
| 05.12.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans | 1 | Seeking Alpha | ||
| 19.11.25 | Vivos Therapeutics GAAP EPS of -$0.49, revenue of $6.8M | 4 | Seeking Alpha | ||
| 19.11.25 | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 | 390 | GlobeNewswire (Europe) | Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference... ► Artikel lesen | |
| 19.11.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 19.11.25 | Vivos Therapeutics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11.25 | Vivos Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 04.11.25 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,880 | -1,70 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,098 | 0,00 % | Sernova Biotherapeutics Inc: Sernova says Swetlow fired over trip, improper payouts | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | +18,31 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,242 | -0,12 % | Plus Therapeutics Inc.: Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide May Reduce Leptomeningeal Metastases Healthcare Costs by 40% | ||
| CARDINAL HEALTH | 179,45 | -1,46 % | Is Cardinal Health Stock Outperforming the Dow? | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives | Kathy Puyana Theall, M.D. and Adebola Giwa, M.D. bring deep expertise across oncology, rare diseases, and global clinical development to support advancement of Atossa's... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,075 | -2,85 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 36,550 | -1,19 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Niedrigere Schätzungen hätten die Kurse in... ► Artikel lesen | |
| FRESENIUS | 43,690 | -1,82 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - JPMorgan hat das Kursziel für Fresenius von 53,60 auf 56,60 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktie bleibt zudem auf der "Analyst Focus List"... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | -1,38 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für FMC mit einem fairen Aktienwert von 56 Euro auf "Kaufen" belassen. Die Transformation des Dialyse-Anbieters sei abgeschlossen, nun könne... ► Artikel lesen | |
| GERRESHEIMER | 21,600 | +21,76 % | Shortseller-Positionen aktuell: Bechtle, Cancom, flatexDEGIRO, Gerresheimer, Kontron, SMA Solar, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,100 | -2,35 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,400 | -0,85 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen VIVOS THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,225 Euro und damit -5,04 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.